TY - JOUR
T1 - HIV and AIDS Epidemic in Kenya: An Overview
T2 - Special Issue on Clinical Pharmacy
AU - Lupia, Rodgers
AU - Chien, Shu-Chen
PY - 2012/8
Y1 - 2012/8
N2 - Kenya is home to one of the world's worst HIV and AIDS epidemics. Approximately 1.5 million people are living with HIV, and an estimated 1 million children have been orphaned by the virus. The prevalence peaked in 2000 and, according to the latest figures (2010), has dramatically dropped to around 6.3%. Although many people in Kenya are still not being reached with HIV prevention and treatment services, access to treatment is increasing. More than half of adults who need treatment are receiving it, with around 100,000 additional adults on treatment in 2010 than in 2009. In comparison, the number of infected children receiving antiretroviral treatment is extremely low. Around 170,000 children are eligible to receive treatment, yet only around 1 in 5 has access to it. The knowledge and tools for preventing HIV transmission are available worldwide, but AIDS control in Kenya is apt to be for naught unless strong efforts are implemented toward the reduction of poverty, ignorance, and in the control of other common sexually transmitted diseases. In this review, we provide an overview of the impact of HIV and AIDS in Kenya, and then discuss the various strategies that have been used to address the scourge.
AB - Kenya is home to one of the world's worst HIV and AIDS epidemics. Approximately 1.5 million people are living with HIV, and an estimated 1 million children have been orphaned by the virus. The prevalence peaked in 2000 and, according to the latest figures (2010), has dramatically dropped to around 6.3%. Although many people in Kenya are still not being reached with HIV prevention and treatment services, access to treatment is increasing. More than half of adults who need treatment are receiving it, with around 100,000 additional adults on treatment in 2010 than in 2009. In comparison, the number of infected children receiving antiretroviral treatment is extremely low. Around 170,000 children are eligible to receive treatment, yet only around 1 in 5 has access to it. The knowledge and tools for preventing HIV transmission are available worldwide, but AIDS control in Kenya is apt to be for naught unless strong efforts are implemented toward the reduction of poverty, ignorance, and in the control of other common sexually transmitted diseases. In this review, we provide an overview of the impact of HIV and AIDS in Kenya, and then discuss the various strategies that have been used to address the scourge.
KW - AIDS
KW - antiretroviral drugs (ARVs)
KW - antiretroviral therapy (ART)
KW - HIV
KW - Kenya
KW - Malawi
UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-84865741422&origin=resultslist&sort=plf-f&src=s&st1=HIV+and+AIDS+Epidemic+in+Kenya&nlo=&nlr=&nls=&sid=6e2c5e819c72ec2abdd7a78d1de2dcc7&sot=b&sdt=b&sl=45&s=TITLE-ABS-KEY%28HIV+and+AIDS+Epidemic+in+Kenya%29&relpos=65&citeCnt=4&searchTerm=
UR - https://www.scopus.com/results/citedbyresults.uri?sort=plf-f&cite=2-s2.0-84865741422&src=s&imp=t&sid=46570864c43a424e055d394aad10a365&sot=cite&sdt=a&sl=0&origin=recordpage&editSaveSearch=&txGid=b14fd98163d6d3d7ced4370bc7d7ec1a
U2 - 10.1016/j.jecm.2012.06.007
DO - 10.1016/j.jecm.2012.06.007
M3 - Article
SN - 1878-3317
VL - 4
SP - 231
EP - 234
JO - Journal of Experimental and Clinical Medicine
JF - Journal of Experimental and Clinical Medicine
IS - 4
ER -
